Standard Life Aberdeen »

Kailera Therapeutics shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Kailera Therapeutics shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Kailera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kailera Therapeutics held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kailera Therapeutics by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.1M 140k 22.03

More positions owned by Standard Life Aberdeen

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Cisco Systems (CSCO)
Johnson & Johnson (JNJ)

View all positions for Standard Life Aberdeen

Top funds holding Kailera Therapeutics

Bain Capital Investors
Bain Capital Life Sciences Investors
Rtw Investments
Canada Pension Plan Investment Board
Atlas Venture Life Science Advisors
FMR
BlackRock
Citadel Advisors
Adage Capital Partners GP
Wellington Management Company
Royalty Pharma Sub-Manager
Siren
Vanguard Capital Management
Vanguard Portfolio Management
Geode Capital Management

View all funds holding Kailera Therapeutics